EndotyPIng PreHospitAl de Novo Acute hYpoxemic Respiratory Failure
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorEvangelismos Hospital
About this trial
We attempt to perform dynamic endotyping of critically ill patients presenting in the emergency department with de novo acute hypoxemic respiratory failure (AHRF). We also attempt to identify what clinical, radiological, physiological and biological variables collected early in the course of AHRF correlate with subsequent mortality and/or persistent severe hypoxemia.
Eligibility criteria
Qualifiers
Adult patients (aged >18 years) presenting in the emergency department
De novo acute hypoxemic respiratory failure (requiring oxygen flow rate of 5 liters per minute or more to maintain SpO2 of 90% or more)
Disqualifiers
Age <18 years
Not admitted to the hospital
Postoperative acute respiratory failure (within one week from surgery)
Chronic hypoxemic respiratory failure (requiring long term oxygen therapy at home)
Trial design
Treatments tested in this trial
- Not listed
Trial groups
250 Participants
are grouped into 1 trial groupLocations
1Evangelismos Hospital10676, AthensAttica, Greece
Sponsors and collaborators
Evangelismos Hospital
Lead sponsor
Source ClinicalTrials.gov